NASDAQ · Medical - Diagnostics & Research

SERA (SERA) Stock

$2.05 +0.00% NASDAQ: SERA Healthcare

Valuation

MetricValue
Price$2.05
Market Cap$78.29M
P/E Ratio-2.63
P/B Ratio0.90
P/S Ratio1152.43
EPS (TTM)$-0.67
52-Week High$4.09
52-Week Low$1.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-42.67%
ROA-31.37%
ROCE-49.33%
Gross Margin-1.91%
Operating Margin-642.35%
Net Margin-563.86%
Debt/Equity0.04
Current Ratio1.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-35.0M$-46.0M$-40.0M$-37.0M$-37.0M
Net Profit$-35.0M$-44.0M$-36.0M$-33.0M$-32.0M
EPS$-1.18$-1.43$-1.16$-0.99$-0.67
Op Margin-43164.6%-17034.3%-13013.4%-47577.9%-45066.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$147.0M$116.0M$95.0M$73.0M$102.0M
Total Liabilities$8.0M$17.0M$25.0M$25.0M$27.0M
Cash$59.0M$30.0M$4.0M$4.0M$4.0M
Borrowings$0$3.0M$2.0M$1.0M$2.0M

Latest News

PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE PR Newswire · Jul 9, 2026 SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS PR Newswire · Jun 30, 2026 SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH PR Newswire · Jun 24, 2026 SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY PR Newswire · Jun 23, 2026 All You Need to Know About Sera Prognostics (SERA) Rating Upgrade to Buy Zacks · Jun 19, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-32.0M$-35.0M$-27.0M$-14.0M$-26.0M
Investing Cash Flow$-84.0M$5.0M$0$11.0M$-29.0M
Financing Cash Flow$2.0M$0$1.0M$3.0M$0
Net Cash Flow$45.0M$-29.0M$-26.0M$0$0
Free Cash Flow$-33.0M$-35.0M$-27.0M$-15.0M$-26.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-41.98%
Quick Ratio2.12
Interest Coverage—
Return 1Y-20.00%
Return 3Y-33.54%
Return 5Y-80.36%

Ownership

Insiders Held11.89%
Institutions Held51.57%
Institutions Float Held58.53%
Institutional HolderSharesReport Date
Baker Bros. Advisors, LP5,498,1702026-03-31
Whetstone Capital Advisors, LLC3,306,8892026-03-31
Aberdeen Group plc2,550,7752026-03-31
Vivo Capital, LLC1,650,4402026-03-31
Vanguard Capital Management LLC1,204,1152026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About SERA

SERA is led by CEO Zhenya Lindgardt, employs 63 people, headquartered in US, publicly traded since 2021.

SERA stock trades at $2.05 with a market capitalization of $78.29M. The stock is valued at a price-to-earnings (P/E) ratio of -2.63, price-to-book of 0.90, price-to-sales of 1152.43. Over the past 52 weeks the stock has ranged between $1.56 and $4.09, and currently trades 49.9% below its 52-week high.

On profitability, SERA generates a return on equity (ROE) of -42.67%, return on capital employed of -49.33%, an operating margin of -642.35%, a net profit margin of -563.86%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides